Iovance Biotherapeutics ($IOVA) Insider Trading & Smart Money Activity

Iovance Biotherapeutics, Inc. · Biotechnology · Latest filing Oct 16, 2026

Iovance Biotherapeutics, Inc. ($IOVA) has 1 insider trade and 1 13F position change on file. Insiders filed 1 Form 4 transaction in the last 12 months, none of them open-market purchases or sales.

Insider buyers (12 mo): 0
Insider sellers (12 mo): 0
Net insider $ (12 mo): $0
Congress trades (12 mo): 0
13F moves on file: 1
Analyst ratings on file: 0

IOVA insider buying and selling by quarter

Quarter	Congress buys / sales	13F added / cut
Q1 2026	0 / 0	0 / 0
Q2 2026	0 / 0	0 / 0
Q3 2026	0 / 0	0 / 0
Q4 2026	0 / 0	1 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All IOVA insider, congress, 13F and analyst activity

Date	Source	Who	Action	Shares	Value / amount	ΔOwn	1W	1M	6M	Filing	Story
Oct 16, 2026	13F	Tema Etfs	Added	+187.43K sh	$6.93M						—
Jun 16, 2026	Insider	Ryan Maynard	Buy (Grant or award)	90.32K sh			+16.2%	+22.0%			Read

1W / 1M / 6M = how IOVA moved from the trade or filing date.

Insider trading in IOVA: who is buying and selling

Insider	Role	Trades	Open-market net	Shares held	Last trade
Ryan Maynard		1	—		Jun 16, 2026

Institutions moving IOVA (13F)

Tema Etfs1

Frequently asked questions

What is the latest insider trade in IOVA?

Ryan Maynard filed a buy (grant or award) of 90.32K sh on Jun 16, 2026.

Which institutions changed their IOVA positions?

Recent 13F filers moving the stock include Tema Etfs.

Other biotechnology stocks

All stocks Insider cluster buys Top insider purchases Congress 13F institutions

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text